These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1779893)
1. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Yamori S; Tsukamura M Microbiol Immunol; 1991; 35(10):921-6. PubMed ID: 1779893 [TBL] [Abstract][Full Text] [Related]
2. [Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains]. Tsukamura M; Yamori S Kekkaku; 1990 Aug; 65(8):519-25. PubMed ID: 2214513 [TBL] [Abstract][Full Text] [Related]
3. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases. Yamori S; Ichiyama S; Shimokata K; Tsukamura M Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364 [TBL] [Abstract][Full Text] [Related]
4. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex]. Tsukamura M Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509 [TBL] [Abstract][Full Text] [Related]
5. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens. Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615 [TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Zimmer BL; DeYoung DR; Roberts GD Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626 [TBL] [Abstract][Full Text] [Related]
7. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Banks J; Jenkins PA Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264 [TBL] [Abstract][Full Text] [Related]
8. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Tomioka H; Sato K; Saito H Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Hoffner SE; Svenson SB; Källenius G Eur J Clin Microbiol; 1987 Oct; 6(5):530-5. PubMed ID: 3436314 [TBL] [Abstract][Full Text] [Related]
10. Mycobacterium avium complex develop resistance to synergistically active drug combinations during infection. Hoffner SE; Heurlin N; Petrini B; Svenson SB; Källenius G Eur Respir J; 1994 Feb; 7(2):247-50. PubMed ID: 8162976 [TBL] [Abstract][Full Text] [Related]
11. Microcalorimetric studies of the initial interaction between antimycobacterial drugs and Mycobacterium avium. Hoffner SE; Svenson SB; Beezer AE J Antimicrob Chemother; 1990 Mar; 25(3):353-9. PubMed ID: 2338413 [TBL] [Abstract][Full Text] [Related]
12. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs]. Tsukamura M Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819 [TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance. van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674 [TBL] [Abstract][Full Text] [Related]
14. In vitro testing of clarithromycin in combination with ethambutol and rifampicin against Mycobacterium avium complex. Stauffer F; Dörtbudak O; Lahonik E Infection; 1991; 19(5):343-5. PubMed ID: 1839300 [TBL] [Abstract][Full Text] [Related]
15. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium]. Ogawa K; Miwa T; Sasamoto M; Sasaki T; Tsuda M; Honda K; Furui H; Torii K; Takagi K Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866 [TBL] [Abstract][Full Text] [Related]
16. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay. Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs. Tomioka H; Sato K; Saito H; Yamada Y Microbiol Immunol; 1989; 33(6):509-14. PubMed ID: 2770562 [TBL] [Abstract][Full Text] [Related]
18. The absence of genetic markers for streptomycin and rifampicin resistance in Mycobacterium avium complex strains. Portillo-Gomez L; Nair J; Rouse DA; Morris SL J Antimicrob Chemother; 1995 Dec; 36(6):1049-53. PubMed ID: 8821605 [TBL] [Abstract][Full Text] [Related]
19. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Heifets L Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162 [TBL] [Abstract][Full Text] [Related]
20. Different correlations of drug susceptibilities to colonial morphology in Mycobacterium avium complex strains. Tsukamura M; Mizuno S; Miyama A Microbiol Immunol; 1989; 33(12):1001-11. PubMed ID: 2622394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]